Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucocorticoids plus rituximab vs glucocorticoids plus placebo in newly-diagnosed or relapsing IgA vasculitis
2020-000729-13Phase 3Active
- Sponsor
- Hôpital Foch
- Start
- Jan 2024
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Henoch-Schönlein Purpura (HSP) comparing Glucocorticoids plus rituximab with Glucocorticoids plus placebo (2 arms). Primary endpoint: Primary remission endpoint. Started Jan 2024; status: active.
02
Drugs
rituximab
03
Conditions
Henoch-Schönlein Purpura (HSP)
Beyond the preview
Go deeper on 2020-000729-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000729-13.